Chiusura precedente | 6,68 |
Aperto | 6,75 |
Denaro | 6,76 x 1800 |
Lettera | 6,76 x 800 |
Min-Max giorno | 6,69 - 6,88 |
Intervallo di 52 settimane | 4,22 - 9,59 |
Volume | |
Media Volume | 830.074 |
Capitalizzazione | 2,556B |
Beta (5 anni mensile) | 1,08 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -0,52 |
Prossima data utili | 26 feb 2024 - 01 mar 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 7,83 |
SCOTTSDALE, Ariz., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 7th Annual Bernstein Healthcare Services Disruptors Conference, which will be hosted in New York City, NY. Details of the presentation are as follows:Presenter: Dave Bourdon, CFODate: Wednesday, October 4, 2023 Time: 8:30 a.m. (Eastern time)Moderated by: Lance Wilkes
SCOTTSDALE, Ariz., Aug. 28, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 21st Annual Morgan Stanley Global Healthcare Conference, which will be hosted in New York City, NY. Details of the presentation are as follows:Presenters: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor RelationsDate: Monday, September 11, 2023 Time
SCOTTSDALE, Ariz., Aug. 09, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2023. (All results compared to prior-year comparative period, unless otherwise noted)Q2 2023 Highlights and FY 2023 Outlook Total revenue of $259.6 million increased $50.1 million or 24% compared to total revenue of $209.5 millionTotal clinicians of 6,132 up